Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and NeckGlenn J. Hanna, Robert I. Haddad, Charles T. Quinn et al.|Clinical Cancer Research|2021Cited by 104
Does Clearance of Positive Margins Improve Local Control in Oral Cavity Cancer? A Meta‐analysisMustafa G. Bulbul, Mark A. Varvares, Osama Tarabichi et al.|Otolaryngology|2019Cited by 88
Association of Pretreatment Circulating Tumor Tissue–Modified Viral HPV DNA With Clinicopathologic Factors in HPV-Positive Oropharyngeal CancerEleni M. Rettig, Glenn J. Hanna, Annette A. Wang et al.|JAMA Otolaryngology–Head & Neck Surgery|2022Cited by 70
Personalized ctDNA for Monitoring Disease Status in Head and Neck Squamous Cell CarcinomaGlenn J. Hanna, Eleni M. Rettig, Michael J. Dennis et al.|Clinical Cancer Research|2024Cited by 48